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INTRODUCTION 
 
Breast reconstruction after mastectomy has evolved over the last century to 
be an integral component in the therapy for patients with breast cancer. Breast 
reconstruction originally was designed to reduce post mastectomy complications 
and to correct chest wall deformity, but its value has been recognized to extend 
past this limited view of use. The goals for patients undergoing reconstruction are 
to correct the anatomic defect and to restore form and breast symmetry. The 
surgical options for breast reconstruction involve the use of endoprostheses 
(implants), autogenous tissue transfers, or a combination of both. 
 
In post mastectomy patients, the body image may result in negative 
psychological consequences. Replacement of the breast restores the self-image that 
may be lost as a consequence of mastectomy. Reconstruction of the breast mound 
has consistently improved with multiple techniques that are selected on the basis of 
the extent of the defect and the patient’s and surgeon’s preferences.  
 
The optimal timing of breast reconstruction is controversial; Patients also 
suffer a distortion particularly when postoperative radiotherapy is likely to be 
required. Immediate breast reconstruction, which has been demonstrated to be 
oncologically safe, spares the patient from the psychological trauma of waking 
from the mastectomy operation without a breast mound and allows fewer hospital 
admissions and anesthetics. Furthermore, the cosmetic outcome of immediate 
reconstruction may be superior to delayed reconstruction. Within the last 30 years 
the technical emphasis has focused on the use of tissue expanders with implants, 
latissimus dorsi myocutaneous transfer, and the transverse rectus abdominis 
myocutaneous (TRAM) flap and free flaps to achieve adequate breast restoration. 
Although all of these methods are individually sufficient for reconstruction, 
surgical feasibility and patient preference dictate their use. 
 
Reconstruction with the latissimus dorsi myocutaneous flap produces a 
breast with ptosis and projection while maintaining the natural consistency and feel 
of normal tissue. This flap provides ample bulk for reconstruction due to the large 
surface of the muscle. In many patients, the flap can be used without the use of an 
implant, restoring volumes of up to 1.5 L in large patients or with the use of 
modified techniques. It restores the anterior chest wall with healthy tissue, 
particularly of benefit in patients who previously have undergone irradiation. The 
flap also provides tropic stimulation to the surrounding tissues without increased 
disease morbidity or interference with mammographic evaluation. 
Within the last 30 years the technical emphasis has focused on the use of 
tissue expanders with implants, latissimus dorsi myocutaneous transfer, and the 
transverse rectus abdominis myocutaneous (TRAM) flap to achieve adequate 
breast restoration. Although all of these methods are individually sufficient for 
reconstruction, surgical preference is based on patient’s condition, stage of the 
disease, option of the surgeon and the patient option. 
 
 
  
AIM OF THE STUDY 
 
The aim of this study is to explain the advantages of immediate post 
mastectomy reconstruction of breast to the patients and convince them for the 
same as they are not aware of such procedures in government setup.  
 
Also to evaluate the reliability of various flaps in post mastectomy breast 
reconstruction. 
 
To setup a surgical protocol depending on the disease status, patient physical 
condition and reliability of the flaps. 
REVIEW OF LITERATURE 
 
Iginio Tansini first used the technique of transfer of the latissimus 
dorsi muscle on its anterior arc of rotation in 1897. This Italian surgeon 
presented his novel concept for the coverage of chest wall defects 
that resulted from breast amputation as it was performed during this 
period. The latissimus dorsi muscle flap and overlying skin were 
rotated anteriorly about the axillary insertion. Later, in 1912, Stefano 
d'Este performed a version of this procedure described by Tansini for 
reconstruction of the mastectomy defect      . 
In 1936, Hutchins went into extensive detail of his use of the 
latissimus dorsi for prevention of lymph edema that occurred after 
mastectomy. He hypothesized that the ipsilateral arm and chest 
morbidity was due to the destruction of the axillary lymphatics and 
subsequent scarring that occurred after removing the pectoralis 
major and minor. Therefore, by re-establishing the axillary lymphatic 
framework imparted by these muscles with the transfer of the 
latissimus dorsi, he found that lymph edema could be attenuated. 
The latissimus dorsi was believed to be a mirror image of the 
pectoralis muscles, and it could serve to mimic the soft tissue defect 
left after removal of these structures. Hutchins described 12 
successful cases in his report, in which he also noted that the 
latissimus dorsi transfer was useful in preventing edema while 
concurrently providing a healthy base for skin grafts and laying the 
foundation for reconstruction of the breast using transposed 
abdominal fat grafts. 
Davis in 1949 and Darrell Campbell in 1950 made use of the 
flap for correction of anterior thoracic wall defects. Davis 
reconstructed a 30 x 14-cm defect created after resection of rib 
chondrosarcoma. The lesion, which extended from the mid axillary 
line to the sternum and spanned the fourth to seventh ribs, was 
covered using a fascia lata graft and an overlying pedicle graft from 
the anterior portion of the latissimus muscle. 
Around the same time, Campbell included the use of the 
latissimus dorsi anterior pedicle in a description of a procedure for 
repair of thoracic wall lesions that were the result of surgical 
extirpation of locally invasive malignancy. In his procedure, he also 
used a fascia lata graft with latissimus dorsi, which subsequently was 
covered by a split-thickness skin graft. The experience of both 
surgeons corroborated Hutchins' findings that the latissimus dorsi 
anterior pedicle muscle flap was a reliable flap that provided 
protection and elasticity to the chest wall as well as adequate 
nutrition to adjacent structures. 
In 1974, Brantigan published the results of 10 years of 
experience using the same procedure. Brantigan treated 22 patients 
using the Hutchins modification of the radical mastectomy and 
reported excellent cosmetic results vis-à-vis the typical radical 
mastectomy. He also demonstrated the use of this flap in covering 
more extensive resections involving the internal mammary lymph 
chain, giving the surgeon the security of having mobile tissue 
between the pleura and skin. 
The work done in the late 1970s presaged the contemporary 
use of the latissimus dorsi flap for breast reconstruction. With the 
understanding of the vascular connections to the skin provided by 
the underlying muscle and the idea of a myocutaneous flap 
proposed by McCraw in 1977, the use of the latissimus dorsi was 
expanded to include the overlying skin island. William Schneider 
reported successful transfer of the muscle and skin combination. He 
found the latissimus dorsi myocutaneous flap particularly useful for 
restoration of breast volume, replacement reconstruction after mastectomy in 
patients with radiation damage to the skin and chest wall of the lost subclavicular 
contour once provided by the pectoralis major muscle, and restoration of deficient 
skin following mastectomy. Olivari, in 1976, and Muhlbauer and Olbrisch, in 
1977, further exploited the latissimus dorsi myocutaneous flap for breast  
In1976, Millard described a tubed lower abdominal pedicled flap for 
reconstruction of breast. Following Mathes’ initial description of vascular anatomy 
and use of the rectus abdominis musculo cutaneous flap for abdominal wall 
reconstruction, Robbins described a vertical rectus abdominis flap for breast 
reconstruction. 
The TRAM flap is considered to be the first choice in autogenous breast 
reconstruction today. The original TRAM flap which was first described by a 
plastic surgeon from Atlanta, Carl Hartrampf Jr., is the TRAM pedicled flap based 
on a single rectus abdominis muscle. In the TRAM pedicled flap, the skin and 
tissue remain attached to the vertically oriented rectus abdominis muscle and are 
supplied with blood from blood vessels that traverse that muscle. The rectus 
abdominis muscle, in turn, is supplied with blood from the superior epigastric 
artery and vein, blood vessels that enter the muscle from under the ribcage and 
course through the muscle and into the flap. Provided that these blood vessels 
remain intact, the amount of blood received by the flap is usually enough to keep 
approximately two thirds of the tissue area alive and available for use in 
reconstructing the breast.  
The deep inferior epigastric perforator (DIEP) flap, a surgical techniques 
which is continuously being refined, in order to improve patient safety, reduce 
operative time and improve flap reliability. Due to the significant variation in 
vascular anatomy of the abdominal wall, precise preoperative mapping of the 
perforating vessels would be invaluable in the planning for flap reconstruction. 
Furthermore, it would reduce intra operative decision-making (such as deciding 
which perforator to use) potentially contributing to a significant reduction in 
operative time. For example, if there is a long intra-muscular course, it is 
preferable to perform a muscle-sparing transverse rectus abdominis 
musculocutaneous (TRAM) flap (MS-2), rather than a DIEP flap. This is because, 
the extensive muscular dissection required in this situation offsets any advantages 
of a DIEP flap. It follows that accurate preoperative decision-making on the mostly 
appropriate abdominal flap for a particular patient should result in faster operative 
times, improve patient safety and flap reliability. 
With the incorporation of microsurgery in breast reconstruction, refinements 
in this flap have produced a free flap with a robust blood supply, less muscle and 
fascia harvest, and success rates approaching 100%. 
Unfortunately, not all patients are candidates for free TRAM flap. Previous 
use of the TRAM flap, TRAM failure, or previous surgery preventing harvesting of 
the flap has led to the development of other methods of autogenous reconstruction 
with free tissue transfer. 
Depending upon the patient's body habitus, one or more of these distant 
flaps can provide the amount of skin and soft tissue needed. 
For these difficult situations, the reconstructive surgeon must have a 
working knowledge of these flaps. 
 
The history of different types of flaps is as follows: 
Superior gluteal free flap 
• In 1976, Fujino first described the superior gluteal myocutaneous free flap 
for breast reconstruction. 
Inferior gluteal free flap 
• In 1978, LeQuang performed the first breast reconstruction with an inferior 
gluteal free flap. 
Lateral transverse thigh free flap 
• The lateral transverse thigh free flap (LTTF) is a horizontal variant of the 
vertical tensor fascia lata myocutaneous free flap.  
• Designed by Elliott in 1989, the LTTF is based on cadaver studies of ink 
injections into the lateral circumflex femoral artery. 
Latissimus flap 
• In the late 1970s, the latissimus flap was the most popular form of 
autogenous tissue breast reconstruction.  
• Used as a pedicled flap based on the thoracodorsal vessels, the flap is 
versatile and reliable. However, for most breast reconstructions performed 
today, the latissimus dorsi flap is used in conjunction with an implant to 
achieve adequate breast volume and projection. 
 MATERIALS AND METHODS 
  
 The study was conducted in the Department of Plastic Surgery, Government 
General Hospital, and Madras Medical College over a period of 33 months July 
2006 to April 2009. All cases of post mastectomy breast reconstruction were 
included in the study.  The proforma for the collection of data was made. All the 
relevant details of the patient during preoperative, surgical, and postoperative and 
follow up periods were collected and analyzed. All patients in addition to routine 
investigation were submitted to Doppler examination of the vascular pedicle near 
the flap donor site. 
 Patient selection: 
Inclusion criteria:  
Post-excision defects in patients with breast malignancies. 
Women more than 30 yrs of age with palpable breast lump. 
Women with sonographically detected solid lesions. 
The above patients with FNAC or biopsy proved breast carcinoma. 
 
Exclusion criteria: 
  1. Infected wound. 
  2. Patients with peripheral vascular diseases. 
  3. Irradiated patients.  
  4. Patients who cannot withstand prolonged anesthesia. 
 
 Exclusion Criteria 
Patients with Stage III, IV excluded. Patients with co-morbid illness in Stage I, 
II excluded. Also small breasts with tumors and those presenting with 
multicentricity was also excluded from primary reconstruction. 
Delayed reconstruction group of patients included where those patient with 
early breast carcinoma (Stage I, II); who had completed chemotherapy or 
completed both chemoradiation therapy. Patients with Stage III, IV excluded.  
Patients with higher grade tumor in I & II excluded.  
Data Sheet was prepared to facilitate the collection of data of all demographic 
details of patients which includes the parameters like name, age, clinical diagnosis, 
investigations and staging of the diseases.  
Data Sheet included type of surgery, type of flap, duration, post operative 
complications. All clinical investigations taken into account where recorded. Post 
operatively with the pathological report, patient was sent for chemotherapy or 
chemoradiation. Follow up period of all patients averaged to 18-30 months. 
Procedure: 
• All cases of stage I & II breast carcinoma were assessed for MRM and flap 
cover, 
• MRM done with axillary clearance done and haemostasis secured. 
• Resultant defect measured. 
• Flaps planned according to the size of the defect, age and general condition 
of the patient. 
• LD/TRAM/DIEP flap done and inset given. 
• Suction drain kept and dressing done 
. 
All patients were retained in Plastic surgery ward until the flap had healed. Patients 
with good general condition were then discharged and reviewed twice a week – if 
the patient lived nearby to the hospital – or once weekly – if the patients were from 
a longer distance. Follow up period varied with individual complaints. 
Statistical Analysis: 
Data will be analyzed using the statistical package at periodic intervals and at the 
end of study. 
 ANATOMY 
 
The adult female breast or mammary gland lies in the subcutaneous 
tissue (superficial fascia) of the anterior thoracic wall. Despite individual 
variations in size, the extent of the base of the breast is fairly constant from 
near the midline to near the mid axillary line and from the second to the 
sixth ribs. It overlies pectoralis major overlapping on to serratus anterior 
and to a small part of the rectus sheath and external oblique muscle. A 
small part of the upper outer quadrant may extend laterally to form the 
axillary tail. It lies in the medial wall of the axilla and may be a discrete 
mass poorly connected with the duct system. Usually it lies in the 
subcutaneous fat, which is condensed around it; rarely it may penetrate the 
deep fascia of the axillary floor and so lie adjacent to some axillary lymph 
nodes.  
 
Some 15-20 lactiferous ducts converge in a radial· direction to open on 
the nipple the projection just below the centre of the breast which is 
surrounded by an area of pigmented skin, the, areola. Some large sebaceous 
glands under the areola (areolar glands) may form small elevations (tubercles 
of Montgomery).  
  
Blood supply  
 
This is derived mainly from the lateral thoracic artery by branches that 
curl around the border of pectoralis major and by other branches that pierce 
the muscle. The internal thoracic artery also sends branches through the 
intercostal spaces beside the sternum; those of the second and third spaces 
are the largest. Similar but small perforating branches arise from the 
intercostal arteries the space superficial to pectoralis major is relatively 
bloodless. Pectoral branches of the thoracoacromial artery supply the upper 
part of the breast. The various supplying vessels form an anastomosing 
network. Venous drainage is mainly by deep veins that run with the main 
arteries to internal thoracic and axillary veins. Some drainage to posterior 
intercostal veins is an important link to vertebral veins and hence a pathway 
for metastatic spread to bone. Superficial veins may anastomose across the 
midline. 
 
Lymph drainage  
 
This is of the utmost importance in connection with the spread of 
malignant disease. From numerous lymphatic capillaries in the breast 
substance and the overlying skin, lymph from the lateral part of the breast 
(upper and lower outer quadrants) drains to axillary and infraclavicular 
nodes while from the medial part (upper and lower inner quadrants) it 
drains through the intercostal spaces into internal thoracic (parasternal) 
nodes. The lateral part draining laterally and the medial part medially, but it 
is important to note that there can be lymph flow between the lateral and 
medial parts of the breast and vice versa, possibly aided by the pressure of 
clothing or the examiner's hand. Some nodes may be embedded within 
breast tissue in the upper outer quadrant, and some may lie between 
pectoralis major and minor. There are no valves in the intramammary 
channels. Most lymph drains to the axilla; some of the internal thoracic 
nodes, which are mainly in the first three interspaces within 3 cm of the 
sternal margin, are very small and may easily be missed. Superficial 
lymphatics may cross the midline.  
 
Nerve supply  
 
The overlying skin is supplied by the cutaneous branches of intercostal 
nerves T4 to T6. Sympathetic fibres supply the blood vessels and glands, 
but the control of lactation is hormonal. 
 
 
                   
 
 
 
 
 
 
 
 
 
 
BREAST CANCER 
 
Cancer of the breast is the second most common cancer in women, 
and the second leading cause of cancer death after lung cancer. The 
majority of women with breast cancer today is eligible for breast 
conservation therapy and receives some form of systemic adjuvant CT. 
 
RISK FACTORS 
 
There are several exogenous and endogenous risk factors identified which 
are as follows 
¾ Age of female > 65years 
¾ Gender 
¾ Family history 
¾ Reproductive history –  Early menarche 
        First birth after age of 30years 
        Late menopause 
¾ Benign breast disease – Atypical hyperplasia 
                                           Lobular carcinoma in situ 
¾ Personal history – Exogenous factors 
           Dietary factors 
 
Hereditary breast cancer accounts for 5 – 10% of cases and caused by the presence 
of BRCA gene mutation. 
 
 PATHOLOGY 
 
A ductal element undergoes a sequence of premalignant stages as follows and turns 
into malignancy. 
 
Normal breast  Æ hyperplasia Æ atypical hyperplasia Æductal carcinoma in situ 
Æ invasive carcinoma. 
 
1) Ductal carcinoma in situ: 
Cancer confined by the basement membrane of the ducts – 
presents as mammographic micro calcification. This occurs in 
varying propensity to progress to invasive cancer. 
Comedo DCIS – pleomorphic cells high grade nucleus and 
central areas of necrosis. 
Non – comedo DCIS – not as malignant as comedo DCIS. It is 
difficult to differentiate it from atypical hyperplasia. 
2) Invasive ductal carcinoma: 
 Majority of breast cancer. 
Appears as grey white irregular, speculated mass that is hard 
and gritty on section. 
No specific microscopic features. 
Recognized as invasive adenocarcinoma involving ductal 
elements. 
3) Medullary carcinoma: 
Grossly soft and fleshy and accounts for 6% of invasive 
carcinoma. 
Large size and well circumscribed. 
Histopathologically, poorly differentiated nuclei and infiltration 
by lymphocytes – favorable prognosis. 
 
 
 
4) Tubular carcinoma: 
2% of breast cancer. 
Small and found on mammography. 
Highly differentiated. 
Has excellent prognosis. 
5) Mucous or colloid carcinoma: 
Well differentiated. 
Histology – nests of tumor cells surrounded by a mucinous 
matrix. 
6) Lobular carcinoma in situ: 
Arises from the epithelium of the breast lobules. 
No radiologic or physical manifestation. 
Traditionally not regarded as malignancy. 
Takes 20years to turn to malignant in 20% of the cases. 
7) Infilterating lobular carcinoma: 
Occurs in 5 – 15% of individuals. 
Similar prognosis as ductal carcinoma. 
Extensive infiltration without a tumor mass. 
No micro calcification. 
Difficult to detect in mammography. 
 
 STAGING 
AMERICAN JOINT COMMITIEE ON CANCER TNM STAGING 
SYSTEM FOR BREAST CANCER 
TNM Staging  
 
Primary Tumor (T)  
Definitions for classifying the primary tumor (T) are the same forctinlcal and for 
pathologic classification. If the measurement is made by the physical examination, 
the examiner uses the major headings (T1, T2, or T3). If other measurements, such 
as mammographic or pathologic measurements, are used, the subsets of TI can be 
used. Tumors should be measured to the nearest O. lcrn increment.  
TX   Primary tumor cannot be assessed  
TO   No evidence of primary tumor  
Tis       Carcinoma in situ  
Tis (DCIS)  Ductal carcinoma in situ  
Tis (LClS)  Lobular carcinoma in situ  
T1  Tumor 2 cm or less in greatest dimension 
Tlmic  Microinvasion O. I cm or less in greatest dimension 
Tla   Tumor more than O. I cm but not more than 0.5 cm in greatest dimension  
Tlb  Tumor more than 0.5 cm but not more than I cm in greatest 
dimension  
TIc   Tumor more than I cm but not more than 2 cm in greatest dimension  
T2  Tumor more than 2 cm but not more than 5 cm in greatest dimension  
T3  Tumor more than 5 cm in greatest dimension  
T4 Tumor of any size with direct extension to (a) chest wall or (b) 
skin, only as described below  
T4a  Extension to chest wall, not including pectoralis muscle  
T4b Edema (including peau d'orange) or ulceration of the skin of the 
breast or satellite skin nodules confined to the same breast  
T4c  Both T4a and T4b  
T4d  Inflammatory carcinoma  
 
 
  
Regional Lymph Nodes (N)  
 
NX  Regional lymph nodes cannot be assessed  
NO  No regional lymph node metastasis  
N1  Metastasis to movable ipsilateral axillary lymph node(s)  
N2 Metastases in ipsilateral axillary lymph nodes fixed to one another          
(matted) or in clinically apparent ipsilateral internal mammary 
nodes in the   absence of clinically evident axillary lymph node 
metastasis  
N2a Metastases in ipsilateral axillary lymph nodes fixed to one another 
(matted) or to other structures  
N2b Metastases only in clinically apparent ipsilateral internal mammary 
nodes and in the absence of clinically evident axillary lymph node 
metastasis  
N3 Metastasis in ipsilateral infraclavicular lymph node(s). with or 
without  axillary lymph node involvement, or in clinically apparent 
ipsilateral internal mammary lymph node(s) and in the presence of 
clinically evident axillary lymph node metastasis; or metastasis in 
ipsilateral supraclavicular lymph node(s). with or without axillary or 
internal mammary lymph node involvement  
N3a   Metastasis in ipsilateral infraclavicular lymph node(s)  
N3b   Metastasis in ipsilateral internal mammary lymph node(s) and axillary 
lymph node(s)  
N3c   Metastasis in ipsilateral supraclavicular lymph node(s)  
 
 
 
Distant Metastasis (M)  
 
MX   Distant metastasis cannot be assessed  
MO   No distant metastasis  
M 1   Distant metastasis 
 
 
 
 
 
 
 
 
Stage Grouping  
 
Stage 0  Tis  NO  MO  
Stage I  T1  NO  MO  
Stage IIa  TO  N1   MO  
  T1  Nl   MO  
  T2  NO  MO  
Stage IIb  T2  Nl   MO  
  T3  NO  MO  
Stage IIIa  TO  N2   MO  
  T1  N2   MO  
  T2  N2   MO  
  T3  N1   MO  
  T3  N2   MO  
Stage IIIb  T4  NO  MO  
  T4  N1   MO  
  T4  N2   MO  
Stage IIIC  Any T  N3   MO  
Stage IV   Any T  Any N  M 1  
 
 
Stage I & II   early breast cancer 
Stage III   LABC – poor prognosis 
    Rx – CT, surgery & RT  
 
 LOCOREGIONAL TREATMENT 
 
GOALS  1) provide optimal local control 
   2) adequate disease staging 
   3) long term survival 
   4) presentation and restoration of body form 
 
 
Total mastectomy and axillary dissection – MRM - is the standard treatment. 
 
SPREAD lymphatic spread 
  Blood stream 
 
Combined systemic therapy with more conservative locoregional treatment 
provides local disease control with prolonged survival. 
 TOTAL MASTECTOMY 
MODIFIED RADICAL MASTECTOMY 
 
¾ Removal of the entire breast NAC and skin overlying the tumor along 
with axillary lymph nodes is the most common treatment followed. 
¾ Pectoralis major and minor are usually preserved. 
¾ Skin sparing mastectomy preserves the inframammary fold and as 
much native skin is possible – used in our series of immediate breast 
reconstruction. 
 
 
 MANAGEMENT OF THE AXILLA 
 
PROGNOSTIC MEDIATOR IN CANCER BREAST 
 
1. Pathological staging 
2. Control of regional disease 
 
POTENTIAL COMPLICATIONS 
 
1. Arm stiffness 
2. Number 
3. Lymphedema 
 
 
Sentinal node biopsy identified and removal of lymph node is most likely to 
contain metastasis. 
False negative – 0 to 11% 
 TREATMENT OF DCIS 
 
Malignant potential of DCIS depends on 
1. The size of tumor 
2. Grade of tumor 
3. Presence of comedo necrosis 
 
 
• May progress to invasive carcinoma. 
• Local recurrence after surgery excision alone is 30% 
• Radiation therapy reduces local recurrence. 
• Immediate post operative radiotherapy is dependant on the local tissue healing 
and type of tissue exposed for radiotherapy. 
• Immediate breast reconstruction helps in post operative radiotherapy, which can 
be given at the earliest to avoid tumor spread after surgical healing. 
 
 
Local recurrences depends on 
• Nuclear grade 
• Size 
• Comedo histology 
• Surgical margins 
 
• Tumor size 
• Tumor grade 
• Presence of comedo necrosis 
 
Silverstein et al
Van Nuys prognostic index 
 POST MASTECTOMY RADIOTHERAPY 
 
 
¾ Reduces the risk of locoregional recurrences by approximately 67% 
¾ But cardiac toxicity reduces the survival. 
¾ Post operative radiotherapy is definitely indicated in patients with                 
≥4 LN positive 
¾ Post implant chest wall irradiation increases the incidence of capsular 
contracture and implant exposure. Hence this was not done in our study. 
¾ It also has a delirious effect on TRAM evidence by increased incidence of 
fibrosis, fat necrosis and revision surgery. 
¾ Only a few cases in our study TRAM was done 
 
Post operative necrosis – incidence – 10% 
 
 
 SYSTEMIC THERAPY 
 
Adjuvant chemotherapy and hormonal therapy is used to eliminate occult 
metastasis responsible for local recurrences upto 30% 
 
COMMONLY USED CHEMOTHERAPY  
• CMF ( cyclophosphamide, methotrexate, 5 fluorouracil ) 
• FAC ( 5 fluorouracil, doxorilicin, cyclophosphamide ) 
• AC ( doxorilicin, cyclophosphamide ) 
• Taxanes ( paclitaxel, docetaxel ) 
• Hormonal ( tamoxifen – selective oestrogen receptor modulator ) in 
oestrogen responsive tumor. 
• Aromature inhibitors ( anastrozole, latrozole ) – blocks peripheral 
conversion of adrenal steroids to oestrogen. 
• Hormonal therapy used in post menopausal and oestrogen responsive 
tumors. 
 
 NODE NEGATIVE TUMORS 
 
Risk of local recurrences even in node negative tumors is 30%. Hence adjuvant 
therapy reduces recurrences and has beneficial effects even in node negative 
tumors. However, a low subset of patients with tumor < 1cm, histology with 
tubular, medullary, mucinous, which have excellent prognosis may be left without 
adjuvant therapy. In our study, as the patients come in late stage of disease, this 
possibility is ruled out. 
 NEOADJUVANT CHEMOTHERAPY 
 
 
Pre operative chemotherapy is indicated in locally advanced disease and operable 
invasive carcinoma who may also have adjuvant chemotherapy. The goal is to 
shrink the tumor and permit breast conservation. Neoadjuvant chemotherapy 
shows significant tumor down staging with pathological complete response rate of 
12 to 25%.
 OPERATIVE TECHINIQUE 
 
 
Autologous tissue reconstruction provides the patient with a reconstructed breast 
tissue with her own tissue obviating the potential complications associated with a 
prosthesis. The disadvantage being donor site scar and potential morbidity. 
 
LATISSMUS DORSI FLAP: 
The latissimus dorsi myocutaneous flap is reliable and richly vascularised flap and 
the proximity if the flap to the chest wall makes it an ideal choice for providing 
muscle, fat and skin for use in reconstructing the breast after mastectomy. Sacrifice 
of the muscle creates a negligible functional deficit. By using implants under the 
flap the volume can be increased to restore the breast to its normal size and 
contour. 
 
 SURGICAL ANATOMY 
 
Triangular muscle with surface area of 105-192sqcm (broadest of the back) 
Arises from  
• Spines of the lower six thoracic & supraspinatous ligament. 
• Lumbar and sacral vertebra through thoraco-lumbar fascia. 
• External lip of the crest of the ilium. 
• Three or four lower ribs by fleshy digitations. 
• Inferior angle of scapula. 
 
 
  
 
 
y Lat & sup borders are free 
y Superior fibers become at first posterior and then inferior 
y Curves around the lower border of the Teres major 
y Ends in a quadrilateral tendon and is inserted into the bottom of the inter-
tubercular groove 
y  Functional resting length 15-22cm 
 
  
 
Arterial anatomy: 
y Dominant supply  
                - Thoracodorsal artery 
y Secondary supply  
                – Posterior intercostal artery & lumbar artery perforators. 
y Can survive even if either pedicle is interrupted 
 
 
 
Vascular supply 
 
• Pedicle arises from the thoracodorsal vessels. 
• Subscapular artery arises from axillary artery, divides into the circumflex 
scapular and thoracodorsal arteries. 
• Before entering into the muscle, gives branches to serratus anterior & 
cutaneous branches 
• Thoracodorsal artery enters at 8.5cm distal to subscapular origin & 2.5cm 
from lateral border. (D=2-3mm) 
• Bifurcates into medial and larger lateral branches within the muscle 
• Rich anastomoses dominant & segmental vessels 
• Accompanying veins follow the arteries and drain into axillary vein 
 
Nerves 
 
• By the sixth, seventh, and eighth cervical nerves through the thoracodorsal 
(long subscapular) nerve. 
• Cutaneous sensation by IC branches(2branches)  & lateral branches of Post 
rami (3 branches)  
Marking 
• With the patient in the standing position 
• The midline of the back is marked along with the tip of the scapula 
• With the arm raised, the sweep of the superior border of the latissimus 
muscle can be drawn in as it courses over the tip of the scapula to the 
midline of the back. 
• The anterior border of the muscle is identified and marked as it runs 
inferiorly from the posterior border of the axilla to the iliac crest. 
• The center of the muscle is identified and the relaxed skin tension line, 
which passes through this point, is drawn 
• A gentle ellipse is drawn around the circular skin island, tapering off 
medially and laterally so as to provide a smooth postoperative scar. 
• Skin paddle in transverse or oblique. 
• Maximum dimensions permitting direct closure is 30X12cm 
• Arm abducted in 90*, NV hilus is marked midway between the insertion at 
the arm and the chest wall. 
• Axillary artery palpated and a point 10cm inferior marked in the sulcus 
between LD and serratus anterior. 
 
 
 
 TRAM FLAP 
 
INDICATIONS  
 
Patients who require a flap and in whom the latissimus dorsi musculocutaneous 
flap is not available include the following:  
 
(1) Those with a previous thoracotomy transecting latissimus muscle, those 
with congenital absence or severe atrophy of the muscle, those in whom the 
muscle was previously as a free flap, or those in whom a previous. 
Latissimus muscle flap failed. 
(2) Those with a modified radical mastectomy in whom the inferior half of 
the pectoralis major muscle has been resected or denervated, resulting in by 
of that muscle 
(3) Those in whom the pectoralis major muscle is completely intact but 
inadequate skin is, available to allow for adequate mound formation; and  
(4) Who strongly prefer a donor-site scar on the anterior abdominal wall 
instead of the back. 
 
 
ANATOMY 
 
The rectus abdominis is a long, broad strap muscle, broader above and 
extending the full length of the anterior abdominal wall. It arises from the fifth, 
sixth, and seventh.  
Costal cartilages above and inserts into the crest of the pubis below. It is separated 
from its fellow by the linea alba in the midline. Three tendinous intersections 
interrupt the muscle fibers; these are at the level of the umbilicus below, at the 
free end of the xyphoid process above, and midway between these two.  
 
The rectus abdominis muscle is enclosed in the rectus sheath, which is 
formed by the splitting of the aponeurosis of the intemal oblique muscle. The 
sheath consists of an anterior and posterior lamina. The anterior lamina is 
reinforced by the aponeurosis of the external oblique muscle; and the posterior 
lamina is reinforced by the aponeurosis of the transversus abdominis muscle. This 
fascial arrangement exists from the costal margin above to a variable level below, 
usually midway between the umbilicus and the symphysis pubis. At this level, the 
posterior sheath ends in a curved margin called the arcuate line. This is 
particularly important in the restoration of abdominal wall integrity after raising 
the rectus abdominis muscle or musculo-cutaneous flap.  '  
 
This muscle has a dual dominant blood supply, the upper vesselis the 
superior epigastric artery, one of the two terminal branches of the internal 
mammary artery. This descends in the space between the costal and xyphoid 
origins of the diaphragm and enters the rectus sheath at the upper medial extreme 
of the sheath and continues along the posterior surface of the muscle.  
 
The lower vessel is the inferior epigastric artery that arises from the 
external iliac artery above the level of the inguinal ligament. It traverses upward 
and medially on the extraperitoneal tissues, where it perforates the transversalis 
fascia to pass anterior to the arcuate line and continues between the posterior 
rectus sheath and the rectus muscle. Within the muscle, these vessels divide into 
multiple terminal branches that communicate at the level of the umbilicus. Both 
being dominant vessels, either may be ligated and the  
Muscle will survive. 
 
The perforators to the skin overlying the rectus abdominis muscle are of the 
indirect type and traverse the rectus abdominis muscle to supply the overlying skin. 
These lie along the medial third above the level of arcuate line. 
 
FLAP DESIGN AND DIMENSIONS 
 
The flap may vary from 30cm long and 10 t0 15cm width depending on the 
requirements. The axis of rotation is the point of entry of the superior epigastric 
artery into the rectus abdominus muscle at the subcostal. The arc of rotation is 0 to 
180 degrees. 
 
 
OPERATIVE TECHNIQUE 
 
The skin is incised through subcutaneous tissue to expose the anterior rectus 
sheath. Sutures are inserted between the dermis and the anterior rectus sheath to 
prevent a shearing strain on the indirect perforator system. The anterior sheath is 
incised around the margins of the skin element, and superiorly, the anterior rectus 
sheath maybe the rectus abdominis muscle may be detached from the fifth, sixth, 
and seventh costal cartilages to facilitate rotation of the musculo-cutaneous island 
element. The distal end of the muscle is raised from the subjacent transversalis 
fascia, and the inferior epigastric vessels are located, transected, and ligated. The 
lower aspect of the rectus abdominis muscle is transected with cutting cautery 
about two to three fingerbreadths proximal to the pubic crest (Fig. 4B). The flap is 
then rotated into the required position (Fig. 4C and D).  
Above the level of the arcuate line, the anterior rectus sheath is repaired by 
direct approximation with nonabsorbable sutures (Fig. 4E). Below the arcuate line, 
repair of the fascia is vital to prevent a postoperative hernia and may be 
performed, in most cases, by advancement of the medial free incised-in the 
midline, opening the sheath like the pages of a book  .  
 
The muscle is easily dissected from the subjacent posterior rectus sheath by sharp 
and blunt dissections. The muscle is. Raised to the subcostal margin .It is not 
necessary to expose the superior epigastric vessel that enters the muscle medially 
at the subcostal margin. The superior insertion of edge of the aponeurosis of the 
external oblique to the linea alba medially. This creates considerable tension that 
is released by a relaxing incision in the fascia of the external oblique far laterally. 
If the defect is too large, a free fascial graft of external oblique fascia harvested 
from the contra lateral side is sutured into position with nonabsorbable sutures 
under suitable tension. Marlex mesh may be used, but autogenous material is 
preferable.  
 
 
 
 
 
COMPLICATIONS 
 
 Serious complications resulting from TRAM flap are fortunately rare. More 
common complications are sub divided into flap complications and donor site 
morbidity. Flap complications consist of total or partial flap necrosis or more 
commonly fat necrosis. If necrosis occur necrotic region debrided and primarily 
sutured or left to heal secondarily. Large areas debrided and closed primarily. 
Abdominal wall complications include hernia,abdominal wall laxity,seroma, flap 
necrosis or wound dehiscence. 
 
 
 
  
DEEP INFERIOR EPIGASTRIC ARTERY 
PERFORATOR FLAP 
 
The DIEAP flap is based on musculocutaneous perforators from the deep 
inferior epigastric branch of the external iliac artery.  
 
The DIEAP flap has become popular for breast reconstruction and is 
particularly indicated in physically active patients as well as in patients who are 
expecting to have children because of complete preservation of the rectus 
abdominis muscle. 
 
Anatomy 
 
Surface markings 
 
The surface markings for the DIEAP flap are similar to those for the TRAM 
flap. There is a concentration of perforators in the periumbilical area and the 
majority of larger caliber perforators are found here. Because of the differences in 
relationship of the skin paddle of perforator flap to the  underlying muscle, it is not 
necessarily constrained by the relationship of the skin to the underlying muscle. The 
skin paddle can theoretically be arranged in any direction around a given 
perforator. For breast reconstruction, however, the standard TRAM skin paddle is 
used. This provides optimal donor site scar placement.  
 
 
 
 Vascular anatomy  
 
The deep inferior epigastric artery originates has a single branch from 
external iliac artery and courses along the inferior surface of the rectus abdominis 
muscle, accompanied by two venae comitantes. It divides into medial and lateral 
branch at the level of middle third of the muscle. The lateral branches preferred 
dominant vascular pedicle for DIEAP flap. Preoperative evaluation of the vascular 
anatomy is helpful in identifying major perforators. Average pedicle length is 
10cm and diameter is 3.6mm. there are about five periambulical perforators larger 
than 0.5mm with in 4cm radius around the umbilicus.  
 
Surgical Technique  
 
The skin markings are similar to those for a TRAM flap. Doppler 
examination of the perforators is performed once preparation and draping are 
complete. The position of the perforators is marked on both sides of the abdomen. 
This is a safe flap to raise because one can use a stepwise 'method in choosing 
perforators as well as in eliminating them. The skin paddle is outlined in exactly 
the same way as in a TRAM flap. One feature that is striking is the asymmetry of 
the perforator from one side to the other. The flap borders are incised. The incision 
cuts through skin and subcutaneous fat down to the deep fascia. Dissection then 
proceeds from lateral to medial at the suprafascial level. As the lateral margin of 
the rectus sheath is approached, care is taken to identify the lateral row of 
perforators. Small vessels can be seen within the fat of the flap as dissection 
proceeds, and these converge toward the vessel of origin. Once this is seen, 
dissection proceeds with caution. The appearance of the perforators at this stage 
often resembles an oak tree. Several features give clues to the size of the 
perforator. One is the actual size of the branches and whether pulsation can be seen 
within them. A useful indicator is the size of the fascial opening through which the 
perforator emerges from the muscle. Very small perforators will be encountered 
and these can be eliminated. Large perforator is identified and dissection proceeds 
by incising the fascia with preservation of a cuff of fascia around the perforator. 
The course of the perforator within the muscle is variable. it either goes straight 
through the muscle to the _ lying branch of the deep inferior epigastric artery or 
runs a more oblique course through the muscle or along the surface of the muscle 
directly under the fascia for a distance before entering the muscle. Once the larger 
deeper vessel is reached, dissection proceeds until sufficient length and calibre is 
achieved. Donor area muscle is preserved. The incised fascia is closed and skin is 
closed primarily. 
 
 
 
 
 CADEVERIC DISSECTiON 
 
With the help of Anatomy and Forensic department six cadaveric dissection 
was done for DIEAP flap. It was found that in all the cadavers the average pedicle 
length and diameter of 10 cm and 3.6mm reapectively. There were 5 to 6 
periumblical perforators within a 4cm radius, arising from medial and lateral row 
of perforators. The lateral row perforators were larger than the medial row ranging 
from 0.4 to 0.5mm. this corresponds to the study don by El-Mrakby and Milner. 
 
DIEP CADAVER DISSECTION 
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OTHER OPTIONS FOR AUTOLOGOUS BREAST 
RECONSTRUCTION 
 
When autologous breast reconstruction is desired but the TRAM and latissimus 
flaps are not available, other flaps have been described for postmastectomy 
reconstruction. The free gluteal flap has been used for breast reconstruction as a 
myocutaneous flap based on either the inferior or the superior vessels. Because of 
the technical complexity of the procedure and complications, including sciatica, 
seroma, unfavorable scar location, and asymmetrical buttock contour, this option is 
a secondary choice for breast reconstruction. The vascular pedicle is quite short, 
requiring either vein interposition or removal of costochondral cartilage to permit 
anastomosis to the internal mammary vessels. 
 The Rubens flap is based on the circumflex iliac vessels. This option is most 
applicable for women who have an excess of soft tissue over the hips, as 
accentuated in women painted by Rubens during the Renaissance. The flap is 
elevated with a full thickness of tissue over the hip and underlying musculature 
including the oblique and transverse muscles. Because this reconstructive 
procedure is limited in bulk and skin envelope and often requires a balancing 
procedure on the contralateral hip, it is not usually considered as a first option. 
 
NIPPLE AREOLA RECONSTRUCTION 
 
The first stage of breast reconstruction centers solely on reconstruction of the 
breast mound. For some patients, merely having a breast mound is all the 
reconstruction that they desire. They are able to appear symmetrical in their 
clothes, including bathing suits. If patients desire nipple-areola complex 
reconstruction, it is performed as a second stage. If the patient is to receive 
adjuvant chemotherapy or radiation therapy, most surgeons prefer to wait until 
after that is completed. Changes in breast mound shape and position on the chest 
wall are expected after surgery and in response to radiation. Therefore, proper 
position of the nipple may not be able to be determined until 2 to 3 months after 
the initial surgery. 
 
The nipple is created from local flaps on the breast mound Numerous different 
techniques have been described, but all have similar limitations. Within 12 months, 
most undergo at least a 50% reduction. Therefore, at the initial surgery, the nipple 
should be made larger than desired. The pigmented areola was originally 
reconstructed with split-thickness skin grafts from the hyperpigmented upper 
medial thigh, labia majora, or retroauricular regions. This has been replaced with 
medical tattooing. pigment is matched to the native nipple areola from the other 
side. Tattooing is performed 3 to 6 weeks after nipple creation. In most cases, the 
pigment fades over time and should be tattooed darker than desired. Because of 
areolar tattoo fading and nipple flap flattening, others have attempted 
cryopreservation of the nipple, which has only produced mediocre results, owing to 
injury to the tissues with the freezing process. Also, as mentioned earlier, 
preservation of the nipple-areolar complex poses an oncologic risks. 
 
 
 
 
 
 
 
 
 
ADVANTAGES OF IMMEDIATE BREAST RECONSTRUCTION 
 
There are four incentives for immediate breast reconstruction including 
decreased psychosocial morbidity, superior cosmetic results, decreased surgical 
morbidity and lower cost. 
 
Psychosocial Benefits 9 
The benefit to psychosocial health is perhaps the prime incentive for immediate 
post- mastectomy breast reconstruction. In the past, many believed that delayed 
reconstruction was better because patients would be more appreciative if forced to 
live for some time with a flat chest wall. This concept is now considered obsolete, 
and many women regard this attitude as evidence of a lack of concern for the 
psychologic impact of mastectomy.Women who undergo immediate reconstruction 
tend to accept the new breast as an integrated part of their bodies and demonstrate 
reduced psychosocial morbidity.19 They have significantly less “distress” in 
recalling the surgery are less likely to be “repulsed” by their own naked appearance 
and have more freedom to dress than women who do not have reconstruction. It is 
difficult to demonstrate a difference in psychologic impact between the various 
reconstructive techniques, but it is reasonable to believe that patients will score 
higher if the reconstructed breast is a true representation of the appearance and 
texture of their natural breast. Compared with breast conservation (i.e., 
“lumpectomy” and radiation), mastectomy and immediate reconstruction yield 
similar psychosocial outcomes. There is no measurable difference in overall 
psychosocial adjustment to illness or satisfaction with relationships or sexual life, 
but there is a specific advantage of breast conservation over breast reconstruction 
in maintaining pleasure and frequency of breast caressing during sexual activity. 
Body image can be adversely affected by the additional scarring associated with 
reconstructive surgery, but the overall psychologic morbidity seems to be the same 
as with breast preservation. Thus, immediate breast reconstruction offers clear 
psychologic benefits compared with delayed reconstruction and it compares 
favorably to breast conservation therapy in psychosocial outcome. 
Cosmetic Benefits 
Immediate breast reconstruction clearly yields superior cosmetic results 
compared with delayed reconstruction. There are two reasons for this. The natural 
tissues that remain after the mastectomy are unaffected by soft-tissue contraction 
and scar. The inframammary fold and other important landmarks that determine 
the unique shape of each woman’s breast are preserved. Retained portions of the 
breast skin envelope tend to assume a natural shape and symmetry when breast 
volume is restored. As a result, the reconstructed breast can assume the shape of 
the patient’s native breast.  
 
Reduced Morbidity 
Immediate reconstruction combines the ablative surgery and reconstruction 
into a single stage, with obvious advantages for the patient. There is lower 
anesthetic risk with one rather than two episodes of general anesthesia. There is 
less inconvenience and time away from family or work because of only one 
hospitalization and period of convalescence for which to prepare. 
The aesthetic results in immediate reconstruction generally are superior, there 
tend to be fewer operations for secondary revision of the reconstructed breast and 
remedial surgery on the opposite breast. 
 
 
 CONTROVERSIES IN IMMEDIATE BREAST 
RECONSTRUCTION 
 
 Is Immediate Reconstruction Oncologically Safe?48 
 
 Women who undergo immediate postmastectomy reconstruction have 
similar survival, as do the patients who do not have reconstruction. Nevertheless, 
immediate breast reconstruction raises three important safety issues: (1) Do 
complications of reconstructive surgery interfere with adjuvant tumour therapies? 
(2) Does skin-sparing mastectomy technique lead to increased local tumor 
recurrence? (3) Will the reconstructed breast conceal tumor and prevent detection 
of local recurrence? 
 
Administration of adjuvant therapy is not delayed in patients who undergo 
immediate breast reconstruction. The usual time from surgery until initiation of 
adjuvant chemotherapy or radiation is 14 to 21 days. This is ample time for 
patients to recover from the additional surgery required for immediate breast 
reconstruction. Immediate reconstruction does not have significantly more 
complications that delay adjuvant therapy, than does mastectomy alone and breast 
skin flap necrosis is not increased if the skin-sparing technique is used properly. 
Significant additional morbidity with delay of chemotherapy has not been seen 
with either breast implants or tissue flaps. Forouhi and co-workers found obesity, 
but not immediate reconstruction to be a significant risk factor for postoperative 
complications that might delay adjuvant therapy. Similarly, Furey found no delay 
in adjuvant therapy because of wound complications and that the frequency of 
wound complications was not increased in patients, receiving adjuvant 
chemotherapy. The author’s experience agrees with these reports. Immediate breast 
reconstruction does not compromise adjuvant cancer therapy. 
 
 
 
What is the Effect of Adjuvant Therapies on the Reconstructive Outcome? 49 
 
Adjuvant therapies are various regimens of radiation and chemotherapy 
given in the absence of evidence of persistent disease after mastectomy. These 
therapies may be administered both before and after the mastectomy to reduce the 
risk of occult distant metastasis. Neoadjuvant chemotherapy (i.e., given before 
surgery to reduce tumor size and assess drug efficacy) has not been shown to cause 
additional morbidity in immediate breast reconstruction. Adjuvant chemotherapy 
also has not been shown to be detrimental to reconstructive outcome. Radiotherapy 
is designed to reduce the incidence of local recurrence, ultimately a uniformly fatal 
event. Therapy can be delivered to a reconstructed breast when indicated without 
difficulty. In patients when reconstruction is done with implants, however, 
radiation significantly worsens the outcome. Expanding irradiated tissues is more 
difficult and painful, and the final reconstructed breast is often too small and hard 
without natural ptosis.  TRAM flaps tend to tolerate irradiation well. 
 
 COMPLICATION RATES OF AUTOGENOUS 
AND NONAUTOGENOUS METHODS 
 
(Trabulsy; Mathes SJ – Plast Recon. Surg. 1994;93 1418-1427) 
Group – I 
1979-1983 
Group – III 
1988-1991 
 
Major Minor Major Minor 
NONAUTOGENOUS  N=133 N=111 
Implants 2(5%) 9(22.5%) 1(6%) 3(18%) 
Tissue Expansion  0(0%) 3(75%) 1(1) 14(17%) 
Latissimus dorsi with 
implant 
1(1%) 15(18%) 0(0%) 2(17%) 
Abdominal advance with 
implant 
0(0%) 2(33%) 0(0%) 0(0%) 
Total 3(2%) 29(21%) 2(2%) 19(17%) 
AUTOGENOUS n=20 n=65 
TRAM 1(5%) 4(20%) 1(2%) 8(15%) 
Free Flap   1(1%) 3(25%) 
Total 1(5%) 4(20%) 2(3%) 11(17%) 
This study concludes that autogenous transplant has less morbidity. 
  
PARTIAL AND TOTAL FLAP LOSS FOR 
AUTOLOGOUS RECONSTRUCTION 
 
Author, Year No of Cases Technique 
Partial or Total 
Flap loss 
Incidence 
Hartrampf, 1987 383 Pedicled TRAM 
flap 
reconstruction  
Partial, 6% 
Total, 0.3% 
Menke,  2001 121 LD flap + 
implant 
Partial, 1.7% 
Total 0% 
Roy,  1998 111 LD flap + 
implant (95%) 
4% Skin and Fat 
Loss 
Chang, 2002 75 Extended LD 
flap without 
implant 
Partial, 5.3%  
Total 0% 
Kroll,  1991 302 TAM Flap, LD 
flap, E/1 
Any: 19.5% 
(includes 
mastectomy flap 
necrosis): 10.6% 
required 
revision. 
 
 
  
INCIDENCE OF INFECTION AFTER FLAP 
BREAST RECONSTRUCTION 
 
Author, Year N Technique Infection 
Incidence 
Hartrampf, 1987 383 breasts Pedicled TRAM 
flap 
reconstruction  
2(0.6%) 
Menke,  2001 121 LD flap + 
implant 
2% 
Roy,  1998 111 LD flap + 
implant (95%) 
8% 
Change, 2002 75 Extended LD 
flap without 
implant  
5.3% 
Schusterman,  
1992 
68 breasts Pedicled TRAM 
or free TRAM 
flap 
8% of pedicled, 
10% of free 
TRAMP flaps 
 
 OBSERVATION & RESULTS 
 
Total number of 18 patients were included in the study over a period of 34 months 
between july 2006 to april 2009. 
AGE INCIDENCE: 
AGE NO. OF CASES 
31 – 40 years 4 
41 – 50 years 8 
51 – 60 years 6 
 
 
 Sides ; Right &  Left – Equal. 
 
 DISCUSSION 
 
In our set up the patients who attended Government hospital, were mostly in 
an advanced stage of the disease. These people are not aware of the progression 
and prognosis of the disease and they also resort to native treatment and some 
rituals. Moreover people who come with early breast cancer are not willing for 
immediate reconstruction procedures. They just want to get rid of the disease and 
are not worried much about cosmetic problem. Hence they have to be convinced 
very much regarding immediate reconstruction which will be helpful for post 
operative radiotherapy and chemotherapy. 
The local recurrence after surgical excision alone is 30%. Radiation therapy 
reduces local recurrence. Immediate post operative radiotherapy is dependant on 
the local tissue healing and type of tissue exposed to rt. Hence immediate breast 
reconstruction helps in post operative rt which can be gien at the earliest to avoid 
tumor spread after surgical handling. 
Post implant chest wall irradiation increase the incidence of capsular 
contraction and implant exposure. Hence it was not done in our study. 
Only stage II disease were selected to produce the post operative morbidity 
and for improving the results. 
An analysis of the study resulted in the following points: 
 
 Patients who came with cancer breast were many, and of them 60% 
were only operable and only 20% were willing for immediate reconstruction 
inspite of explaining to them about autologous reconstruction of breast. Thus, only 
18 patients were included in this study, out of which 10 patients under went LD 
FLAP, 5 patients TRAM FLAP and 3 patients DIEAP FLAP. 
 
  LD FLAP was convenient for the patient as well as for the surgeon as 
there was less extensive dissection and less duration of surgery and relatively nil 
donor site morbidity and the scar was acceptable, but the breast mound was small 
and needed implant for augmentation which was not done at present as the patients 
were not willing for another procedure immediately. Hence it was planned later. So 
also nipple areola reconstruction. 
 
 TRAM FLAP was done in obese patients to provide the added 
advantage of abdominoplasty and scar was hidden under the clothing, but the 
extensive dissection and the need for mesh repair were the disadvantage. 
 
 DIEAP FLAP required expertise on the part of the surgeon and also 
well trained microvascular team and equipment. The duration of surgery was also 
prolonged and patients with co morbid illness were not suitable for this flap. But 
the final result was superb giving a good breast mound in comparison with the 
tram flap, but with less dissection and doesnot require a mesh repair. 
 
 CONCLUSION 
 
 Autologous breast reconstruction is superior to implants. 
 
 Post operative chemo/RT can be given as early as possible after 
reconstruction to prevent tumor spread. 
 
 
 Awareness of breast reconstruction should be stressed to the patients. 
 
 LD FLAP is easier – breast mound small -  needs prosthesis. 
 
 
 TRAM FLAP – extensive dissection – needs abdominal mesh repair. 
 
 DIEAP FLAP with the microvascular team is the best for breast 
reconstruction in terms of breast mound and donor site morbidity. 
 
 
 All cases in our study had aesthetically acceptable results and were subjected 
to post operative RT/CT at the earliest than those who were without 
reconstruction. 
 
 
  
PROFORMA 
 
NAME:                                                             PS No: 
AGE:                                                                ADM No: 
SEX:                                                                 D.O.Adm: 
ADDRESS:                                                      D.O.Surg: 
                                                                          D.O.Dis:  
 
 
                  
    Ph no:   
 
 
 
PRESENTING COMPLAINTS: 
 
  
HISTORY OF PRESENT ILLNESS 
PAST HISTORY:  
Co morbidity: 
PERSONAL HISTORY 
Smoker/ non-smoker  
 
TREATMENT HISTORY 
 
 
 
GENERAL EXAMINATION 
 
 
 
 
CLINICAL EXAMINATION 
 
 
 
 
 
PROVISIONAL DIAGNOSIS:  
 INVESTIGATIONS 
FNAC 
USG Breast 
USG Abdomen 
Mammography  
Skeletal Survey 
Blood Grouping & Typing 
CBC 
RFT 
LFT 
X-Ray Chest 
ECG 
 
 
 
TYPE OF SURGERY 
TYPE OF FLAP 
DURATION OF SURGERY 
Amount of Blood transfusion  
POST OP EVALUATION 
Patient satisfaction  
Patient depression 
Pain 
Flap Necrosis 
Wound Infection 
Donor site seroma 
Pathological evaluation and oncological clearance 
Duration to start chemotherapy 
Chemotherapy compliance 
Radiotherapy compliance 
 
 
POST OPERATIVE 
Breast Symmetry 
Donor site 
Flap 
 Post Operative pain of patient was elicited by categorical scales of pain and 
visual analogue scales. 
 Categorical Scales use words to describe the magnitute of pain. The patient 
pick the most appropriate word. The research group use four category 
Scale.7 
 
Pain Intensity  Score  Visual analogues 
 Severe   : 3  Pain intensity Scale 
 Moderate : 2  Least  ----------------- worst 
 Slight  : 1  
 None  : 0  
 The advantage of categorical scales that they are simple and quick. 
Psychological evaluation was done based on Eysencks personality 
questionnaire and profile of mood states. The questionnaire contained 5 questions 
which included the mood profile. Each questions were given a score of 2 and 
maximum of score 10 was given.  
 
Questionnaire and Scoring  System 
1) Do you now feel that you have lost your breast? 
2) Does your reconstructed breast matches with your opposite breast? 
3) Do you think that you can dress as previously before surgery? 
4) Do you feel that you have lost your feminity? 
5) Do you feel low when compared to other women? 
 
Score : 0-2 – Poor  2-4 Fair 6-10 Good 
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MASTER CHART 
No. Name Age /sex Ip no Diagnosis 
Surgical 
procedure Flap result Donor site Inference 
1 Rajeshwari 45/F 14818 Stage II rt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
2 Mallika 39/F 5695 Stage II rt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
3 Hema 32/F 73490 
Cystosarcoma 
phylloids rt. 
breast 
WLE & LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
4. Selvi 45/F 65919 Stage II lt. breast 
MRM & TRAM 
flap 
Fat necrosis,  
partial 
Primary closure 
,healed well 
Breast mound 
good. 
Wound 
infection  
5 Mary 48/F 2418 Stage II lt. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
6 Jerina 30/F 25341 Stage II lt. breast 
MRM & TRAM 
flap Well settled 
Primary closure 
,healed well 
Breast mound 
good. 
 
7 Bagyalakshmi 50/F 10195 Stage II rt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
8 Kannamma 46/F 17198 Stage II rt. Ca. breast 
MRM & DIEAP 
flap Flap necrosis 
Primary closure, 
healed well 
Necrosed flap 
debrided & 
SSG 
9 Adilakshmi 52/F 61151 Stage II rt. Ca. breast 
MRM & TRAM 
flap Well settled 
Primary closure, 
healed well Excellent result 
10 Chitra 30/F 74515 
Cystosarcoma 
phylloids rt. 
breast 
WLE & LD flap 
cover 
Wound 
dehiscence 
Primary closure, 
healed well 
Wound 
infection 
11 Srimathi 48/F 21555 Stage II rt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
12 Lakshmi 42/F 28830 Stage II rt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
13 Sarala 55/F 31620 Stage II lt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well 
Donor site 
wound 
dehiscence - 
infection 
14 Muniamma 55/F 20965 Stage II rt. Ca. breast 
MRM & DIEAP 
flap Well settled 
Primary closure 
,healed well Excellent result 
15 Jaishree 40/F 8010 Stage II lt. Ca. breast 
MRM &LD flap 
cover Well settled 
Primary closure 
,healed well Excellent result 
16 Lalitha 45/F 64801 Stage II lt. Ca. breast 
MRM & DIEAP 
flap Flap necrosis 
Primary closure, 
healed well 
Necrosed flap 
debrided & 
SSG 
17 Devaki 50/F 11001 Stage II lt. Ca. breast 
MRM & TRAM 
flap 
Partial flap 
necrosis 
Primary closure, 
healed well 
Wound 
infection.  
Debrided 
primary suture.  
18 Muthulakshmi 52/F 11715 Stage II lt. Ca. breast 
MRM & TRAM 
flap Well settled 
Primary closure 
,healed well Excellent result 
  
